Predictions for 2017 are everywhere this time of year, and it is no wonder. There are so many technological advances, in health care and elsewhere, and a seemingly endless appetite for them. We all want the latest and greatest gadgets, we all want the most modern treatments, we all have come to increasingly rely on technology, and we all -- mostly -- see an even brighter technological future ahead. Here's my meta-prediction: some of the predicted advances won't pan out, some will delight us -- and all will end up surprising us, for better or for worse. Like Father Time and entropy, the law of unintended consequences is ultimately undefeated...
Acquired Immune Deficiency Syndrome (AIDS)
See the following -
'Virtual Doctors' Helping Patients in Zambia
Sean Coughlan | BBC | June 22, 2016
The idea of a "virtual doctor" project might sound rather futuristic. But the inspiration for this scheme to improve health services in Zambia began in very low-tech and unhappy circumstances. Huw Jones, working in Zambia as a safari guide, was driving a Land Rover along a road in a remote part of the country. He saw a trail of blood in the road, and his first reaction was that it might have come from an animal killed by a lion. But he came across a couple on a bike - the man riding and the woman carried on the handlebars. She was pregnant and bleeding heavily and they had been cycling for hours with the aim of reaching the nearest hospital, almost 60 miles away...
- Login to post comments
2017 Prediction: Some "Oops" Ahead
By Kim Bellard | January 4, 2017
- Login to post comments
A Major Lesson from Ebola: Pandemics Are Strongly Driven by Inequality
By Michael Baker | May 25, 2015
After more than a year since the Ebola pandemic appeared in West Africa, Liberia – one of the worst hit countries – has been declared free of the virus. However, the initial global response was not encouraging. Despite having the knowledge and technology needed to contain the outbreak, help was initially sluggish and poorly effective. This situation illustrates one of the major lessons from the history of pandemics: that they are strongly influenced by health inequalities. Pandemics are epidemics that spread widely and cross borders. In many respects, the world is a safer place for those concerned about these emerging infectious diseases – advances in science, particularly molecular biology, information technology, and epidemiology give us unprecedented tools for understanding, tracking and managing emerging threats...
- Login to post comments
Bill Gates Won’t Save You From The Next Ebola
Robert Fortner | Huffington Post | April 30, 2017
In late August 2014, Tom Frieden, then director of the Centers for Disease Control and Prevention, traveled to West Africa to assess the raging Ebola crisis. In the five months before Frieden’s visit, Ebola had spread from a village in Guinea, across borders and into cities in Liberia and Sierra Leone. Médecins Sans Frontières, the first international responder on the scene, had run out of staff to treat the rising numbers of sick people and had deemed the outbreak “out of control” back in June...
- Login to post comments
Breaking Good: School Students Make Costly Drug Cheaply Using Open Source Approach
Press Release |
University of Sydney |
November 30, 2016
Sydney Grammar students, under the supervision of the University of Sydney and global members of the Open Source Malaria consortium, have reproduced an essential medicine in their high school laboratories. The drug, Daraprim, had been the subject of controversy when the price was hiked from US $13.50 to US$750 a dose last year. Daraprim - originally used as an antimalarial after its synthesis by Nobel Prize winner Gertrude Elion - is now more widely used as an anti-parasitic treatment for toxoplasmosis, which can be a dangerous disease for pregnant women and people with compromised immune systems, such as those living with HIV or AIDS...
- Login to post comments
Building an Open Medical Records System for the Developing World
By Don Watkins | August 19, 2016
How do you introduce a woman whose very life is the epitome of humanitarian efficacy? Judy Gichoya is a Kenyan medical doctor specializing in radiology and an experienced programmer who's accelerating the growth of OpenMRS. According to its website, "OpenMRS is a software platform and a reference application which enables design of a customized medical records system with no programming knowledge." Judy first got interested in computers in high school, prior to entering medical school she learned to program at a technical college and through online resources on the internet...
- Login to post comments
Epipen: A Sign of a Broken Healthcare System
Tanya Feke | Diagnosis Life, LLC | October 13, 2016
It has been going on for years. The difference is that now the media is hopping on the story. Now America is paying attention. In 2015, the price of doxycycline, a generic antibiotic, was up to $5 per pill, an increase from $0.03 in 2014. The antibiotic is the gold standard treatment for Lyme disease. In 2015, the price of Daraprim (pyrimethamine), was up to $750 per pill, an increase from $13.50. The antiparasitic medication is used to toxoplasmosis, an infection acquired in people who have HIV/AIDS...
- Login to post comments
How Community Health Centers Support Patient-Centered Care
Sara Heath | Patient Engagement HIT | August 21, 2017
Each year, HHS celebrates Community Health Centers week. It is a time where the agency recognizes the impact community health centers have on patient-centered care and how they promote access to care in vulnerable or medically underserved populations...
- Login to post comments
Hurricane Harvey: Responding to Public Health and Infectious Disease Threats
Press Release |
Infectious Diseases Society of America (IDSA) |
August 31, 2017
The membership of the Infectious Diseases Society of America and the HIV Medicine Association stand with the individuals, families and communities affected by flooding in the aftermath of Hurricane Harvey, and urge care, preparation and precautions in confronting health impacts that may pose risks in the days and weeks ahead. We would like first to emphasize that while widespread disease outbreaks after flooding remain uncommon in the United States, hand hygiene, clean water, as well as access to medications will be essential for preventing and limiting the spread of infectious diseases during this time...
- Login to post comments
Martin Shkreli Congratulates Australian Students for Recreating Life-Saving Drug
Staff Writer | Fortune | December 2, 2016
Former pharmaceutical executive Martin Shkreli has congratulated a group of Australian students who reproduced the active ingredient for a life-saving, anti-parasitic drug at the centre of a drug-price controversy involving his former company. The students from Sydney Grammar School drew global media attention this week after they said they had produced the drug Daraprim for about $2 a dose, a fraction of the current list price of $750 per dose. Shkreli is a former chief executive of Turing Pharmaceuticals, where he sparked outrage among patients and U.S. lawmakers for raising the price of Daraprim by more than 5,000%...
- Login to post comments
Mobile Technology for Community Health (MOTECH) Suite
Mobile Technology for Community Health (MOTECH) Suite is an open source enterprise software package designed by the Grameen Foundation to connect popular mHealth technologies to strengthen healthcare systems by streamlining patient data collection and improving patient engagement. MOTECH has the capacity to reach illiterate patient populations as well as patient populations in rural areas and works by connecting frontline worker systems such as CommCareHQ, eHealth systems such as OpenMRS and DHIS2, and communication systems such as IVR, SMS, and email to improve healthcare delivery. The MOTECH platform is designed to work effectively in low-resource settings, apply to a broad range of health domains, and meet the needs of large patient populations.
- Login to post comments
MOTECH: How An Open Source SMS Medical Platform Is Improving Patient Engagement and Reaching Underserved Populations in Developing Nations
By Julie M. Smyth | June 4, 2017
Implementation of the MOTECH Suite is spreading rapidly among government health services and humanitarian organizations that address the health of potentially vulnerable or at-risk populations across the globe. As an open source solution, MOTECH affords a number of advantages for health services, particularly in low resource areas of the world. Organizations or individuals who work with software solutions to healthcare-related humanitarian issues will need to know what MOTECH is, how it works, and how it might be used to improve the health of various populations...
- Login to post comments
Mylan Isn't Alone: 11 Drugmakers with Off-the-Charts Pricing Power
Matt Krantz | USA Today | August 25, 2016
Mylan (MYL) is drawing fire for passing off massive price hikes for its EpiPen allergy treatment. But it’s far from being the drug company with the most pricing power. Gilead (GILD), Biogen (BIIB) and Amgen (AMGN), along with eight other drug giants in the Standard & Poor's 500, enjoyed off-the-charts pricing power on their products relative to costs — far beyond Mylan's, according to a USA TODAY analysis of data from S&P Global Market Intelligence...
- Login to post comments
Peer into the Post-Apocalyptic Future of Antimicrobial Resistance
Michael T. Osterholm and Mark Olshaker | Wired | March 18, 2017
Aout 4 million years ago, a cave was forming in the Delaware Basin of what is now Carlsbad Caverns National Park in New Mexico. From that time on, Lechuguilla Cave remained untouched by humans or animals until its discovery in 1986—an isolated, pristine primeval ecosystem. When the bacteria found on the walls of Lechuguilla were analyzed, many of the microbes were determined not only to have resistance to natural antibiotics like penicillin, but also to synthetic antibiotics that did not exist on earth until the second half of the twentieth century...
- Login to post comments
Peer into the Post-Apocalyptic Future of Antimicrobial Resistance
Michael T. Osterholm and Mark Olshaker | Wired | March 18, 2017
Aout 4 million years ago, a cave was forming in the Delaware Basin of what is now Carlsbad Caverns National Park in New Mexico. From that time on, Lechuguilla Cave remained untouched by humans or animals until its discovery in 1986—an isolated, pristine primeval ecosystem. When the bacteria found on the walls of Lechuguilla were analyzed, many of the microbes were determined not only to have resistance to natural antibiotics like penicillin, but also to synthetic antibiotics that did not exist on earth until the second half of the twentieth century...
- Login to post comments
Copyright ©2011-2020 Open Health Marketplace, LLC. All Rights Reserved.